Activation of integrin α5 mediated by flow requires its translocation to membrane lipid rafts in vascular endothelial cells Local flow patterns determine the uneven distribution of atherosclerotic lesions. Membrane lipid rafts and integrins are crucial for shear stress-regulated endothelial function. In this study, we investigate the role of lipid rafts and integrin α5 in regulating the inflammatory response in endothelial cells (ECs) under atheroprone versus atheroprotective flow. Lipid raft proteins were isolated from ECs exposed to oscillatory shear stress (OS) or pulsatile shear stress, and then analyzed by quantitative proteomics. Among 396 proteins redistributed in lipid rafts, integrin α5 was the most significantly elevated in lipid rafts under OS. In addition, OS increased the level of activated integrin α5 in lipid rafts through the regulation of membrane cholesterol and fluidity. Disruption of F-actin-based cytoskeleton and knockdown of caveolin-1 prevented the OS-induced integrin α5 translocation and activation. In vivo, integrin α5 activation and EC dysfunction were observed in the atheroprone areas of low-density lipoprotein receptor-deficient (Ldlr −/− ) mice, and knockdown of integrin α5 markedly attenuated EC dysfunction in partially ligated carotid arteries. Consistent with these findings, mice with haploinsufficency of integrin α5 exhibited a reduction of atherosclerotic lesions in the regions under atheroprone flow. The present study has revealed an integrin-and membrane lipid raft-dependent mechanotransduction mechanism by which atheroprone flow causes endothelial dysfunction.
integrin | lipid rafts | shear stress | proteomics | endothelial dysfunction S hear stress imposed on vascular endothelial cells (ECs) influences vascular phenotype and function. Atherosclerosis preferentially develops at branches and curvatures in the arterial tree where flow is disturbed. In contrast, pulsatile shear stress (PS) in the straight parts of the arteries is atheroprotective (1) . At the cellular and molecular levels, disturbed flow pattern increases, while PS inhibits, the inflammatory response in ECs, including the expression of intercellular adhesion molecule 1 (ICAM-1), vascular adhesion molecule 1 (VCAM-1), and interleukin 1β (IL-1β) (2) . We found that integrins in ECs are shear stress-sensitive (3) . Many subsequent studies demonstrated that integrin activation is essential for transmitting mechanical stimuli to intracellular biochemical pathways (4) (5) (6) . Additionally, mounting evidence indicates that lipid raft microdomains, membrane receptors, cytoskeletal proteins, and extracellular matrices are linked to integrin activation in the context of mechanotransduction (7) (8) (9) (10) (11) . However, the key mechanism underlying the differential effects of atheroprone versus atheroprotective flows in activating integrins that in turn induces inflammatory response in ECs remains to be elucidated.
Lipid rafts are membrane microdomains that are enriched in cholesterol, sphingolipids, and a variety of signaling molecules, which function as cellular signaling platforms. These microdomains are more ordered and tightly packed than the surrounding membrane. Removal of membrane cholesterol leads to the dissociation of molecules from lipid rafts and hence deactivation of some of these molecules (12) . The F-actin-based cytoskeleton associates with lipid rafts, and many of the structural and functional properties of rafts require an intact F-actin-based cytoskeleton. As many of the lipid raft-associated proteins in ECs are shear stress-sensitive, changes in the cholesterol content of the membrane or disruption of its F-actin-based cytoskeleton abolish mechanosensitivity of the cell.
Both oxidized low-density lipoprotein (OxLDL) and atheroprone flow have been implicated in inducing nuclear factor-κB (NF-κB)-mediated inflammation in ECs. Integrin α5β1 is mainly expressed in ECs (13) and is involved in flow activation of NF-κB (14) . With respect to lipid rafts, clustering of ganglioside-abundant lipid rafts has been shown to regulate the activity of integrin β1 (15) . Furthermore, a recent study by Yurdagul et al. shows that integrin α5β1 is involved in OxLDL-induced activation of NF-κB in ECs (16) . Although it is firmly established that activation of α5β1 mediates the NF-κB inflammatory axis in ECs, it is unknown whether a common molecular basis exists between the ability of atheroprone flow and OxLDL to activate integrin α5β1 and the subsequent molecular mechanisms by which α5β1 increases the inflammatory response, leading to atherosclerosis susceptibility.
The current study was initiated from findings from a quantitative proteomics analysis of lipid raft-associated proteins in ECs regulated by flow. Surprisingly, this high-throughput screening revealed that oscillatory shear stress (OS) drastically increased integrin α5 in lipid rafts of ECs. Because OxLDL treatment of ECs increases their membrane cholesterol content leading to Significance This study reveals that atheroprone flow induces integrin α5 translocation into lipid rafts and hence activation to cause endothelial dysfunction in vitro and in vivo. Consequently, this mechanotransduction event leads to the activation of NLRP3 inflammasome. Knockdown of integrin α5 ameliorated endothelial cell (EC) dysfunction in partially ligated carotid arteries of Ldlr −/− mice. Furthermore, haploinsufficiency or functional inhibition of integrin α5 in mice improved EC function in the atheroprone area. These findings reveal a novel mechanism by which atheroprone flow causes endothelial dysfunction that leads to vascular impairments such as atherosclerosis.
decreased membrane fluidity (17, 18) , we hypothesized that alterations in cholesterol composition or lipid packaging in lipid rafts in response to OxLDL or atheroprone flow may alter integrin α5 distribution and/or activity. Furthermore, given that activation of NF-κB in turn activates Nod-like receptor protein 3 (NLRP3) inflammasome (19) , integrin α5 would be upstream of the atheroprone flow-induced NLRP3 inflammasome (20) .
In this study, we investigate the roles of lipid rafts and integrin α5 in OS-induced EC dysfunction, including NLRP3 inflammasome and their causative effect on atherogenesis. Our in vitro and in vivo experiments demonstrate that the lipid raft translocation and activation of integrin α5, due to changes in membrane fluidity, is a previously unidentified pathway mediating endothelial dysfunction in response to atheroprone flow.
Results

Differential Effects of OS and PS on Lipid Raft Translocation and
Activation of Integrin α5. We isolated total proteins from human umbilical vein ECs (HUVECs) that had been exposed to OS (0.5 ± 4 dyn/cm 2 ) or PS (12 ± 4 dyn/cm 2 ) for 2 h. The cell lysates were fractionated using sucrose density gradient ultracentrifugation to separate the lipid raft-associated proteins. Positive blotting of lipid raft markers including flotillin-2 (Flot2), caveolin-1 (Cav1), and cavin1 in fractions 4-5 ( Fig. S1A , Top) validated that these fractions contained the lipid raft-associated proteins. Quantitative proteomic analysis was then performed, and 396 proteins were identified in fractions 4-5 (Datasets S1 and S2). We selected proteins that were significantly upregulated or down-regulated in an OS-or PS-dependent manner. Using the Panther Classification System (www.pantherdb.org) (Dataset S3), we categorized these proteins into different functional groups (binding, enzyme regulator, ion channel, motor, receptor, structural molecular, transcription regulator, translation regulator, and transporter). Of the proteins considered mechanosensitive and significantly differentially regulated, the level of integrin α5 was increased by OS, but decreased by PS, in lipid rafts (1.8-vs. 0.6-fold) (Dataset S3).
To confirm the results from proteomic analysis, ECs were exposed to OS or PS for increasing time points, and the distribution of integrin α5 in lipid rafts was examined. Under OS, the proportion of integrin α5 in lipid rafts increased in a timedependent manner, up to threefold at 2 h. In contrast, PS had an opposite effect (Fig. S1A , Bottom). In support of this observation, we used equal amounts of protein purified from lipid rafts and nonlipid rafts under OS vs. PS to detect integrin α5 translocation. As expected, although OS induced integrin α5 translocation into lipid rafts, which became significant at 2 h, PS promoted the exit of integrin α5 from lipid rafts ( Fig. 1 A and B) .
We next investigated whether OS regulates the activity of integrin α5. Using an antibody recognizing the activated integrin α5, we found that OS, but not PS, activated integrin α5 ( Fig. 1 C  and D) . This differential effect between OS and PS in activating integrin α5 persisted up to 12 h following flow application ( Fig.  S1 B and C). In line with integrin α5 activation, OS enhanced EC adhesion on fibronectin, a specific ligand for integrin α5. By contrast, PS decreased such adhesion ( Fig. S1 D and E). To validate the in vitro observations, we investigated integrin α5 activation in different regions of the aorta of low-density lipoprotein receptor-deficient (Ldlr −/− ) mice on normal diet. En face immunostaining with the use of an antibody recognizing the activated integrin α5 showed enhanced staining in atheroprone areas [i.e., aortic arch (AA)] in comparison with the atheroprotective area [i.e., thoracic aorta (TA)] (Fig. 1E , Top). Noticeably, there was no difference of total integrin α5 expression between TA and AA (Fig. 1E, Bottom) .
Lipid Raft Translocation of Integrin α5 Is Associated with Its
Activation. Western blot analysis shown in Fig. 2A indeed verified that OS activated integrin α5 and that the activated integrin α5 was mainly located in the lipid raft fractions. We then examined the causative effect of integrin α5 translocation and activation, namely, whether α5 translocation is necessary for its activation or vice versa. When we knocked down Cav1 to disrupt the structure of lipid rafts to prevent α5 translocation, OS could not activate α5 nor could it enhance EC adhesion to fibronectin ( Fig. 2 B and C) , which indicates that α5 translocation instigates its activation by OS. However, when ECs were treated with an α5 neutralizing antibody (α5 Ab) or ATN161 (an α5-specific inhibitory peptide) to prevent α5 activation, OS was still able to induce the α5 translocation into lipid rafts (Fig. 2 D and E) . [6] [7] [8] [9] [10] [11] [12] , and whole cellular proteins (Total) in static cells or those exposed to OS or PS. (C and D) Lipid raft proteins were isolated for Western blot analysis of activated integrin α5 (Act-α5) and Flot2, a marker for rafts fractions. Bar graphs show the relative ratio of total or activated α5 to Flot2 or β-actin. ANOVA followed by the Bonferroni post hoc test was used for statistical analysis. Data are mean ± SEM averaged from at least three independent experiments. *P < 0.05, rafts vs. static; # P < 0.05, nonrafts vs. static. (E) The AA and TA were isolated from Ldlr −/− mice (8 wk old; n = 10)
for en face immunostaining with Act-α5 (red), Total α5 (α5, red), Flot2 (green), and nuclear (blue).
Collectively, results in Fig. 2 suggest that the Cav1-dependent integrin α5 translocation into lipid rafts is necessary for its activation by OS but not vice versa.
Integrin α5 Activity Is Regulated by Membrane Fluidity and Cholesterol Content. As membrane fluidity affects the mobility of membrane proteins, and because we previously reported that shear stress regulates cholesterol content of the EC membrane, in turn altering membrane fluidity (21), we next investigated the involvement of membrane fluidity in flow regulation of integrin α5 activity. We found that OS increased 1,6-diphenyl-1,3,5-hexatriene (DPH) anisotropy, which is indicative of a decrease in membrane fluidity (Fig. 3A) . Such change was consistent with the increase in cholesterol content in the membrane (Fig. 3C) . These OS-imposed effects were not seen in ECs pretreated with methyl-β-cyclodextrin (β-CD) to deplete cholesterol ( Fig. 3 A  and C) . In contrast, PS increased membrane fluidity and attenuated cholesterol content, which were abolished if EC cultures were supplemented with cholesterol ( Fig. 3 B and D) . Importantly, cholesterol depletion with β-CD prevented α5 activation by OS (Fig. 3E) , whereas cholesterol supplementation increased the level of activated α5 under PS (Fig. 3F ). These findings suggest that membrane fluidity affected by cholesterol content is crucial for OS activation of integrin α5.
Integrin α5 Translocation Is Mediated by F-Actin-Based Cytoskeleton
Rearrangements. Given the important role of the F-actin-based cytoskeleton rearrangements in protein translocation from the cytoplasm to lipid rafts (i.e., caveolae) (21, 22), we further investigated whether the OS-induced integrin α5 translocation is dependent on F-actin-based cytoskeleton. Disruption of the F-actin-based cytoskeleton by cytochalasin B (Cyt-B) markedly attenuated the OS-induced integrin α5 translocation and activation (Fig. S2) .
OS-Induced EC Dysfunction Is Integrin α5-Dependent. Integrin α5 activates the NLRP3 inflammasome in macrophages (23) , and OS has been shown to induce NLRP3 inflammasome in ECs (20) . Because OxLDL-induced NF-κB is α5-dependent (16) and NF-κB activation primes the induction of NLRP3 inflammasome (19), we reasoned that α5 activation is necessary for OS-induced inflammasome activation. Indeed, the OS-induced cleavage of procaspase1 and pro-IL-1β, hallmarks of NLRP3 inflammasome induction, was reduced by α5 neutralizing antibody in a dosedependent manner (Fig. 4A) . A similar inhibitory effect was seen in ECs in which Cav1 was knocked down (Fig. 4B) . Moreover, there was a decrease in OS activation of NLRP3 inflammasome in mouse embryonic fibroblasts (MEFs) isolated from α5-null embryos (Fig. 4C) . Downstream of the OS-induced NLRP3 inflammasome is the enhanced expression of the chemoattractant and adhesion molecules such as VCAM-1 and ICAM-1. The OSaugmented VCAM-1 and ICAM-1 expression was attenuated by either α5 neutralizing antibody or β-CD treatment (Fig. 4 D and E) . Additionally, the enhanced binding of monocytes to EC , and then exposed to OS for 2 h. Western blot was performed with antibodies as indicated. Bar graphs show the relative ratio of Raft α5 to Flot2, or Nonraft α5 to β-actin. ANOVA followed by the Bonferroni post hoc test was used for statistical analysis. Data are mean ± SEM averaged from at least three independent experiments. *P < 0.05, vs. static. under OS was blocked by both the α5 neutralizing antibody (Fig.  4F ) and Z-YVAD-FMK, a caspase-1 inhibitor (Fig. 4G) . Thus, OS activation of integrin α5 is functionally linked to endothelial dysfunction.
EC Dysfunction in Atheroprone Regions in Vivo Is Integrin α5-
Dependent. To demonstrate the relevance of OS-activated integrin α5 in proinflammatory response in ECs in vivo, we used Ldlr −/− mice subjected to partial ligation of the carotid artery, which induces an acute disturbed flow pattern (24) . Compared with the sham-ligated contralateral artery in the same animal, inflammation was aggravated in the partially ligated artery, as evidenced by the activation of integrin α5 (Fig. 5A ) and the upregulation of VCAM-1 and ICAM-1 (Fig. 5B) . We used adenovirus (Ad)-mediated integrin α5 shRNA to infect partially ligated carotid arteries in Ldlr −/− mice and confirmed the knockdown of integrin α5 (Fig. 5C , first four panels). Compared with control experiments (using Ad-GFP), Adintegrin α5 shRNA decreased the OS-induced expressions of VCAM-1 and ICAM-1 (Fig. 5C, fifth and sixth panels) . Because homozygous deletion of α5 is embryonic lethal, we created α5 +/− mice and their α5 +/+ wild-type littermates to further validate the deleterious role of integrin α5 in inducing EC dysfunction in relation −/− MEFs or littermate wild-type MEFs (α5 +/+ ) were used in C. All cell groups were kept under static condition or exposed to PS or OS for 12 h. In A−E, Western blots were performed for activated integrin α5 (Act-α5), procaspase1 (pro-Casp1), caspase1 p20 (Casp1 p20), pro-IL-1β, IL-1β p17, ICAM-1, and VCAM-1. Lipid raft fractions (Rafts) were used to detect Act-α5, whereas total cell lysates were used for all other proteins. Bar graphs showed the relative ratio of casp1 p20 and IL-1β p17 to β-actin. Data are mean ± SEM normalized to the static control from at least three independent experiments. ANOVA followed by the Bonferroni post hoc test was used. *P < 0.05, vs. static or PS. (F and G) . The BCECF-AM-labeled THP1 cells were added to EC monolayer and incubated for 30 min. Fluorescence microscopy was used to assess the attached THP1 cells. The ratio of adherent THP1 cells to ECs was measured. ANOVA followed by the Bonferroni post hoc test was used for statistical analysis. Data are mean ± SEM averaged from at least three independent experiments. *P < 0.05, vs. static controls. to atherosclerosis. The reduced expression of integrin α5 in α5
mice was verified by en face immunostaining (Fig. 5E ). Haploinsufficiency of integrin α5 markedly blocked the OS-induced expression of VCAM-1 and ICAM-1 in the inner curvature of AA (atheroprone area) of integrin α5 +/− mice, compared with the corresponding area in α5 +/+ littermates (Fig. 5D ).
Atherogenesis in Ldlr
−/− Mice Is Integrin α5-Dependent. We used two different animal models to demonstrate that the OS-regulated α5 is relevant to atherogenesis in vivo. First, 8 wk-old Ldlr −/− and Ldlr
+/− mice were fed a western diet (WD) for 4 wk. The extent of atherosclerosis in the aorta was determined accordingly. There was a ∼50% decrease in total lesion area as well as that in the AA in the Ldlr −/−
/α5
+/− mice ( Fig. 6 A and C) . In a second model, Ldlr −/− mice were fed with WD and injected with ATN-161, which is an inhibitory peptide of integrin α5. Compared with Ldlr −/− mice injected with a scrambled peptide, inhibition of integrin α5 by ATN-161 significantly decreased the total atherosclerosis area. The lesion areas in both AA and TA were decreased by ATN-161 treatment (Fig. 6 B and D) . These data demonstrate the importance of integrin α5 in atherogenesis in the Ldlr −/− mice, similar to that in Apolipoprotein E-deficient (Apoe −/− ) mice, reported by Yurdagul et al. (16) .
Discussion
The present study has revealed a mechanotransduction mechanism by which atheroprone flow causes endothelial dysfunction through integrin α5 translocation into lipid rafts and subsequent activation. Consequently, NLRP3 inflammasome is induced by the activated integrin α5. The results of our proteomics analysis of proteins suggested that OS leads to α5 translocation into lipid rafts. In ensuing studies, we confirmed that OS increased integrin α5 translocation into lipid rafts, and that this was a prerequisite for integrin α5 activation. In contrast, PS caused integrin α5 to reside largely outside lipid rafts, and therefore the activity of α5 showed little changes. We also demonstrated a link between integrin α5 activation and NLRP3 inflammasome induction in ECs under OS. Thus, the novelties of our study are twofold. First, OS activates integrin α5 exclusively in the lipid raft. Second, integrin α5 activation in turn mediates NLRP3 inflammasome induction by OS. Thus, the OS-induced activation of integrin α5, in the context of atheroprone flow and hypercholesterolemia, appears to be an essential step in the atherogenic process. Shear stress may modulate EC functions in a rapid manner through its action on the plasma membrane. We have previously reported that shear stress changes membrane fluidity temporally and spatially (25) . Specifically, OS increases the cholesterol content in EC membranes, which results in decreased membrane fluidity (21) . Such alterations of biophysical properties would affect the structure and function of membrane-associated proteins, especially those found in lipid rafts, such as integrin α5. Significantly, OS, but not PS, induced the translocation of integrin α5 into lipid rafts (Fig. 1) . Because OS increases the cholesterol content of EC membranes, the cholesterol-enriched lipid rafts may thus sequester integrin α5 to allow for its sustained activation. This notion is supported by our previous observation that Cav1 and the F-actin-based cytoskeleton are involved in protein translocation into lipid rafts (21, 22) . Indeed, results in Fig. 2 and Fig. S2 show that Cav1 and F-actin-based cytoskeleton are required for OS-induced α5 translocation.
Atheroprone flow activates NF-κB and increases the expression of chemoattractants (e.g., monocyte chemotactic protein-1) and adhesion molecules (e.g., ICAM-1, VCAM-1) in vitro and in vivo (26) (27) (28) (29) (30) . Recent studies suggest that atheroprone flow regulates gene expression at the genome level via epigenetic regulation, in particular, DNA methylation (31) (32) (33) . At the signaling level, atheroprone flow can induce NLRP3 inflammasome in ECs, which contributes to atherosclerosis susceptibility (20) . The results in Fig. 4 show that functional blocking or genetic ablation of α5 inhibited the OS-induced NLRP3 inflammasome. Because inflammasome induction leads to the increase in the level of IL-1β and IL-18, the OS-induced inflammation in ECs is at least in part mediated by integrin α5 activation of NLRP3 inflammasome. The mechanosensitive integrin α5-inflammation axis in vivo was validated by the loss-of-function experiments with the use of integrin α5 shRNA, and haploinsufficiency of integrin α5 in mice. All these experiments showed decreased EC inflammation under atheroprone flow (Fig. 5 C and D) . Importantly, we demonstrated that the in vivo relevance of integrin α5 activation to the atherogenic process using two different murine models that have either haploinsufficiency of α5 or inhibition of α5 activation by an inhibitory peptide led to marked protection against atherosclerosis even in the presence of sustained hypercholesterolemia. In our studies, we used the WD-fed Ldlr −/− model to test the role of integrin α5 in atherogenesis. The study by Yurdagul et al. (16) also demonstrated the important role of integrin α5 activation for the atherogenic process using the Apoe −/− model; they found that α5 activation could also occur via a different mechanism that involved OxLDL (16) . The fact that integrin α5 was demonstrated to play an obligatory role in atherogenesis in two different murine models (i.e., Ldlr −/− and Apoe −/− ), and can be activated by two different mechanisms (i.e., atheroprone flow and OxLDL), adds to the confidence that this pathway is highly relevant in vivo. It is intriguing that both OS and OxLDL can activate integrin α5 in vitro. Given the reduced atherosclerosis found in the atheroprone areas in the Ldlr −/−
/α5
+/− mice, we propose that OS and OxLDL could share similar mechanism in activating integrin α5. Integrin α5 activation would occur at regions of profound atheroprone flow, where atherosclerosis is most prevalent. Seemingly, OxLDL is not present in the circulation, but it is believed that OxLDL is generated in the intima at sites of lesion formation. How this in turn would lead to EC α5 activation is less clear. Whatever the mechanism is, one could envision the regulation of α5 activation by both mechanical and biochemical actions to play a key role in EC dysfunction and atherosclerosis. This thesis is in line with that proposed by Davies and colleagues that the synergism between flow characteristics and hypercholesterolemia deserves "further evaluation of the epigenetic and epigenomic regulation of endothelial phenotype adaptation during early pathological change" (31, 34) .
In summary, our study reveals a novel mechanism by which atheroprone flow increases endothelial inflammation that involves an integrated response of lipid rafts, F-actin-based cytoskeleton, and integrin α5. Our results provide a novel experimental basis for the use of integrin α5-specific antagonists for preventing dysfunctional endothelium and alleviating atherosclerosis.
Materials and Methods
All animal protocols were approved by Peking University Health Science Center Animal Care and Use Committee. The sources of antibodies and reagents, and detailed methods for cell culture, shear stress, purification of membrane and lipid raft protein, fluorescence anisotropy measurements, iTRAQ labeling and proteomics analysis, en face immunostaining, RNA interference, monocyte adhesion, fibronectin adhesion, carotid partial ligation, generation of α5 +/− mice, adenovirus construction, lesion area assessment, and statistical analysis are described in SI Materials and Methods.
